These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2788568)

  • 21. Supersensitivity of 5,7-dihydroxytryptamine-treated rats to the respiratory depressant and antitussive effects of dihydrocodeine.
    Kamei J; Ogawa M; Kasuya Y
    Eur J Pharmacol; 1988 Aug; 153(2-3):305-8. PubMed ID: 3181291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neonatal 5,7-DHT lesions upregulate [3H]mesulergine-labelled spinal 5-HT1C binding sites in the rat.
    Pranzatelli MR
    Brain Res Bull; 1990 Jul; 25(1):151-3. PubMed ID: 2207701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Receptor mechanisms in increased sensitivity to serotonin agonists after dihydroxytryptamine shown by electronic monitoring of muscle twitches in the rat.
    Stewart RM; Campbell A; Sperk G; Baldessarini RJ
    Psychopharmacology (Berl); 1979 Feb; 60(3):281-9. PubMed ID: 108706
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of 5-HT receptor subtype-selective drugs on locomotor activity and motor habituation in the DHT adult rat model.
    Pranzatelli MR; Jappay E; Snodgrass SR
    Pharmacol Biochem Behav; 1987 Jul; 27(3):497-504. PubMed ID: 3116560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased sensitivity to intracerebroventricular infusion of serotonin and deaminated indoles after lesioning rat with dihydroxytryptamine.
    Warbritton JD; Stewart RM; Baldessarini RJ
    Brain Res; 1980 Feb; 183(2):355-66. PubMed ID: 6153283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonergic mediation of DRL 72s behavior: receptor subtype involvement in a behavioral screen for antidepressant drugs.
    Jolly DC; Richards JB; Seiden LS
    Biol Psychiatry; 1999 May; 45(9):1151-62. PubMed ID: 10331107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effect of serotonin precursor 5-hydroxytryptophan and neurotoxic analogue 5,7-dihydroxytryptamine on defensive conditioning in a snail].
    Tagirova RR; Deriabina IB; Gaĭnutdinova TKh; Andrianov VV; Gaĭnutdinov KhL
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2010; 60(2):201-5. PubMed ID: 20469595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine.
    Lorens SA; Hata N; Cabrera T; Hamilton ME
    NIDA Res Monogr; 1989; 95():347. PubMed ID: 2577039
    [No Abstract]   [Full Text] [Related]  

  • 29. Sensitivity of spinal reflexes to TRH and 5-HT in 5,6-dihydroxytryptamine-treated rats.
    Nagano N; Ono H; Ozawa M; Fukuda H
    Eur J Pharmacol; 1987 Jul; 139(3):315-21. PubMed ID: 3117574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of footshock-induced analgesia by spinal 5,7-dihydroxytryptamine lesions.
    Hutson PH; Tricklebank MD; Curzon G
    Brain Res; 1982 Apr; 237(2):367-72. PubMed ID: 7083000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anorexia and brain serotonin: development of tolerance to the effects of fenfluramine and quipazine in rats with serotonin-depleting lesions.
    Carlton J; Rowland N
    Pharmacol Biochem Behav; 1984 May; 20(5):739-45. PubMed ID: 6610879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of neonatal treatment with 5,7-dihydroxytryptamine or 6-hydroxydopamine on the ontogenetic development of the audiogenic immobility reaction in the rat.
    Hard E; Ahlenius S; Engel J
    Psychopharmacology (Berl); 1983; 80(3):269-74. PubMed ID: 6412273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A general role for serotonin in the control of behavior: studies with intracerebral 5,7-dihydroxytryptamine.
    Vanderwolf CH
    Brain Res; 1989 Dec; 504(2):192-8. PubMed ID: 2598022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of microinjections of 5,7-dihydroxytryptamine in the suprachiasmatic nuclei of the rat on serotonin reuptake and the circadian variation of corticosterone levels.
    Williams JH; Miall-Allen VM; Klinowski M; Azmitia EC
    Neuroendocrinology; 1983 Jun; 36(6):431-5. PubMed ID: 6877522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5,7-Dihydroxytryptamine modifies excitability of rat dorsal raphe serotonergic neurons in vitro.
    Segal M
    Neurosci Lett; 1986 Nov; 71(3):306-10. PubMed ID: 3796886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracortical 5,7-dihydroxytryptamine depletes brain serotonin concentrations without affecting spontaneous activity.
    Black RS; Robinson RG
    Pharmacol Biochem Behav; 1985 Feb; 22(2):327-31. PubMed ID: 3983223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioral evidence for supersensitivity following destruction of central serotonergic nerve terminals by 5,7-dihydroxytryptamine.
    Trulson ME; Eubanks EE; Jacobs BL
    J Pharmacol Exp Ther; 1976 Jul; 198(1):23-32. PubMed ID: 132525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5,7-Dihydroxytryptamine lesions of the ascending 5-hydroxytryptamine pathways: habituation, motor activity and agonistic behavior.
    Hole K; Johnson GE; Berge OG
    Pharmacol Biochem Behav; 1977 Sep; 7(3):205-10. PubMed ID: 563078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serotonin neurotoxins: recent advances in the mode of administration and molecular mechanism of action.
    Baumgarten HG; Jenner S; Klemm HP
    J Physiol (Paris); 1981; 77(2-3):309-14. PubMed ID: 7288647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of hypothalamic injections of 5,7-dihydroxytryptamine on elicitation of mouse-killing in rats.
    Vergnes M; Kempf E
    Behav Brain Res; 1982 Aug; 5(4):387-97. PubMed ID: 6889881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.